Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Diagnostics Market Size to Surpass USD 2,089.32 Million by 2030, Share, Emerging Trends, Competitive Landscape and Regional Overview HOUSTON, Jan. 15, 2023 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's titled "Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Diagnostics Market" with...

UPDATE - InvestmentPitch Media Video Discusses Pascal Biosciences and its Non-Brokered Private Placement to Raise up to $900,000 with $0.10 Units – Video Available on Investmentpitch.com VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pascal Biosciences (TSXV:PAS) (OTCPink:PSCBF) (FSE:6PB), a biotechnology company targeting innovative therapies for serious diseases,...

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market to Reach $3.53 Billion by 2026 at 5.3% CAGR: AMR Portland, OR, Sept. 12, 2019 (GLOBE NEWSWIRE) -- According to a report published by Allied Market Research, the global acute lymphocytic/lymphoblastic leukemia therapeutics market was accounted for...